SPL 0.00% 9.6¢ starpharma holdings limited

Ann: DEP irinotecan outperforms in pancreatic cancer model, page-20

  1. 357 Posts.
    lightbulb Created with Sketch. 31
    I guess they will scale up the dosage with the Colon cancer patients and then when they near the maximum tolerated dose they can use it with the Pancreatic cancer patients.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.7¢ 9.8¢ 9.4¢ $31.52K 323.3K

Buyers (Bids)

No. Vol. Price($)
1 98090 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 103527 4
View Market Depth
Last trade - 14.53pm 29/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.